Feline heart surgery first is ‘way forward’

Dec 18, 2017

A pioneering procedure that saved the life of a kitten with a rare and potentially fatal heart condition could transform the way similar cases are treated in future. In what is believed to be a world first for feline medicine, surgeons from North Downs Specialist Referrals in Surrey successfully performed keyhole surgery on a kitten with a double-chambered right ventricle – a rare condition – meaning it had a severe obstruction on the right side of the heart. Until now, the condition could only be corrected with open-heart surgery. Sylvie recuperating after the successful pioneering cutting balloon angioplasty operation. Image: North Downs Specialist Referrals. The procedure was performed by cardiologist João Loureiro, who believed the kitten was too frail to withstand open-heart surgery, so opted for a keyhole procedure that has historically only been used in dogs, on account of felines having such small hearts. To conduct the cutting balloon angioplasty, Mr Loureiro and fellow cardiology specialist Joel Silva inserted two tiny balloons on a wire into the heart via... ...

Read More

Pimobendan study outcome – a ‘revolution’ for vet cardiology

Nov 13, 2017

A product that delays onset of congestive heart failure (CHF) in dogs by 15 months offers a “paradigm shift” in the way vets diagnose and treat myxomatous mitral valve disease (MMVD). Boehringer Ingelheim, the company behind pimobendan drug Vetmedin, cautiously estimated 7.5% of all dogs would suffer heart disease in their lifetimes, with MMVD its most prevalent form. Vetmedin was already licensed for the treatment of canine CHF from dilated cardiomyopathy or valvular insufficiency, as well as for treatment of cardiomyopathy in the preclinical stage in Dobermann pinschers. However, following the largest clinical trial in veterinary cardiology, the product can now be used by vets to treat the preclinical stage of MMVD, delaying onset of the clinical symptoms of heart failure. At an official launch for the European veterinary press, held in Frankfurt and attended by Veterinary Times, it was noted up to 40 million dogs worldwide could now benefit with treatment from pimobendan. The evaluation of pimobendan in dogs with cardiomegaly (EPIC) study set out to analyse whether long-term... ...

Read More